Blog

CAR T Cells: Exciting, but Who Is Going to Cover Costs? – Medscape


Medscape

CAR T Cells: Exciting, but Who Is Going to Cover Costs?
Medscape
CAR T-cell therapies are basically unchartered territory when it comes to reimbursement from payers. These are not typical therapies with respect to cost structure, he pointed out. "We need to accurately capture charges to agencies like CMS [Centers

2017-12-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.